Skip to content

Author

P. Arlett

We have 2 of 91 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Clinical trials on medicinal products in the EU/EEA, 2013–2025: a cross-sectional analysis of CTIS and EudraCT data

Summary Background The global clinical trial landscape and the European regulatory environment have both undergone substantial change over the past decade. We describe trends in clinical trials on medicinal products in the EU/EEA from 2013 to 2025. Methods We conducted a cross-sectional descriptive analysis of public d...

T. Machado, G. Capone, I. den Rooijen et al. · 0 citations
Review Open access Aug 2026

Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance

This list of 10 priority areas for regulatory science research related to the use of artificial intelligence in the medicine lifecycle aims to support researchers and research funding bodies in addressing knowledge gaps on artificial intelligence in the medicines lifecycle.

Luis C. Pinheiro, Amanda C Langston, M. Orre et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.